Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canntab Therapeutics Ltd CTABF

Canntab Therapeutics Limited is a Canadian phytopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The Company’s operations comprise a single segment engaged in the medical marijuana business. The Company’s hard pill cannabinoid formulations provide doctors, patients, and consumers with medical grade solutions. These include once a day and extended-release formulations. Its products include INSTANT RELEASE - (IR Tablet), EXTENDED-RELEASE - (XR Tablet), and ORAL DISSOLVING - O.D. Tablet (ODT). The IR Tablet is a release profile for solid hard tablets. The XR Tablet is a phytocannabinoid vehicle that is designed to directly address the drawbacks and challenges of competing oral delivery systems. ODT is specifically designed to dissolve directly in the patient’s mouth, with an onset of action between five and thirty minutes.


GREY:CTABF - Post by User

Canntab Therapeutics Ltd > What has happened with this PILL ?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(8)
•••
Comment by Tonydeon Jun 16, 2018 2:38pm
111 Views
Post# 28181821

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:What has happened with this PILL ?

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:What has happened with this PILL ?
fromBelgien, every investor's dream is to make money, on the other hand every investor's nightmare is to find him or herself in red. Although I don't believe that the stock share will hit that low, there is always a possibility. No one can predict the future (unless someone came back from the future, no time travelling exist as of now - as far as I know)!! Canntab has so much going for them that it would be unlikely for the share to drop under the seventy cent (0,70) mark. Regarding the news of Sheldon Inwentash (who set on the Board of Advisors), this shouldn't effects the share price. Don't take me wrong, I'm not saying that he did not contribute to the success of Canntab. I see it as his priorities changed and decided to move on to new (maybe more excited) project. We should join Jeffrey and thank him and wish him success in his future endeavours. Now if our CEO or CFO resigned, that would be a whole different story. As always, this is personal opinion and beliefs.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities